VitaBildung is building a new standard for myopia management — helping clinicians catch progression earlier, and helping patients access the right treatment sooner, regardless of where they're seen.
Most tools either assume a fully-equipped ophthalmology practice, or offer no real clinical structure at all. The gap in between is where patients fall through.
Progression is often flagged only once a child's prescription has already worsened significantly — after the easiest window for intervention has passed.
What a patient is told often depends entirely on which type of provider they happen to see first — there's no shared, standardized pathway.
Surgical correction and specialist care remain financially or geographically inaccessible for a large share of the patients who need help most.
Take our 60-second risk check to see whether your child's myopia pattern is worth a closer look.
VitaBildung is developing a structured myopia management pathway — designed to give every provider, at every level of care, a clear next step.
A structured intake gathers the patient information that actually predicts risk — not just a snapshot of their current prescription.
Risk level maps to a clear set of options — from lifestyle changes through to escalation and specialist referral — suited to what's actually appropriate for that patient.
Review timing and outcome tracking are built into the protocol, so progress — or lack of it — never goes unnoticed for long.
A side-by-side look at how myopia-management tools typically work today, and where VitaBildung's approach diverges.
Early, deliberate, and honest about it — here's the actual sequence, not a polished version of it.
The underlying assessment and treatment-matching logic is built and internally tested against worked clinical scenarios, including a bilateral (two-eye) scoring extension.
A complete invention disclosure is finished and is moving toward attorney engagement: formal prior-art search, then a provisional filing to establish priority.
Every coefficient in the current prototype is a placeholder until it's been checked against real outcomes data. This stage replaces assumptions with evidence before anything reaches a patient.
Hardening the prototype into a deployable application for clinics, with persistent records, role-based access, and a downloadable desktop build.
Paid access for clinics once the platform and the science behind it are both ready — sequenced deliberately, in that order, not the reverse.
Three words, one standard we hold every part of VitaBildung to.
Myopia management has been built around the patients who can already afford full specialist care. We're building for everyone else too.
Every part of the protocol is grounded in published clinical evidence — not assumptions, and not guesswork dressed up as software.
The goal isn't a clever algorithm for its own sake. It's a child who needs a weaker prescription next year than they would have otherwise.
Whether you're a clinician, researcher, or potential collaborator — we'd like to hear from you.